Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2010
07/21/2010CN101780176A Traditional Chinese medicine preparation for treating nervous headache
07/21/2010CN101780175A Method for extracting and preparing total flavones of datura stramonium seed
07/21/2010CN101780169A Traumatic injury analgesic cataplasm preparation and preparation method thereof
07/21/2010CN101780164A Method for treating Morinda officinalis extract by using membrane integration technology
07/21/2010CN101780148A Nymphaea tetragona chewable tablet and preparation method thereof
07/21/2010CN101780147A Anti-inflammatory and hypoglycemic mulberry leave extract and preparation method of preparation thereof
07/21/2010CN101780146A Quality control method of Biqi capsules
07/21/2010CN101780145A Medical stone mineral health-care product
07/21/2010CN101780137A Processing method of honey-fried liquorice
07/21/2010CN101780129A Method for extracting active ingredients of Mongolian medicament echinops latifolius
07/21/2010CN101780124A Capparis acutifolia sweet exact and preparation method and application thereof
07/21/2010CN101780120A Medicinal effect activities of extract of mixture of Poria cum Ligno Hospite and ganoderma and application in medicine
07/21/2010CN101780101A Application of low-molecule heparin in medicament preparation
07/21/2010CN101780093A Application of progesterone for preparing medicament for treating cerebral apoplexy and cerebral acute reactive inflammation
07/21/2010CN101780057A Transdermic absorption patch
07/21/2010CN101780051A Preparation methods of potassium sodium dehydroandroan drographolide succinate and freeze-dried powder injection thereof
07/21/2010CN101780030A Ginkgo flavone aglycone solid dispersion and preparation method thereof
07/21/2010CN101780020A Cool and refreshing toilet water capable of relieving itching and expelling mosquito
07/21/2010CN101239159B Chinese medicinal composition for treating rheumatoild disease and preparation thereof
07/21/2010CN101229344B Chinese traditional medicine composite for treating heart disease and preparing method thereof
07/21/2010CN101129902B Application of disease-eliminating drink in preparing medicine for treating menorrhalgia and uterine gland myopathia
07/21/2010CN101077183B Novel capilary artemisia red date composite health care beverage and its processing technology
07/21/2010CN101049387B Composition of Chinese traditional medicine for treating rheumatic bone disease
07/20/2010US7759526 Pharmaceutical compositions comprising cannabidiol derivatives
07/20/2010US7759486 2,4,5-Trisubstituted pyrimidine compounds
07/20/2010US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759388 Phenylalanine derivatives
07/20/2010US7759385 opioid receptor ligands such as {4-[3-(1H-indol-3-yl)-pyrrolidine-1-yl]-1-phenyl-cyclohexyl}-dimethylamine dihydrochloride salt, used as analgesics
07/20/2010US7759380 Substituted pyrrolines as kinase inhibitors
07/20/2010US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
07/20/2010US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
07/20/2010US7759337 N-cyclopropyl-4-methyl-3-{1-[(2R)-2-methylpiperazin-1-yl]phthalazin-6-yl}benzamide, useful for the prophylaxis and treatment of protein kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders
07/20/2010US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus
07/20/2010US7759326 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
07/20/2010CA2547234C The use of quaternary pyridinium salts as vasoprotective agents
07/20/2010CA2529983C Preoperative treatment of post operative pain
07/20/2010CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
07/20/2010CA2447865C Novel sulfonic acid derivatives
07/20/2010CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis
07/20/2010CA2411831C Pharmaceutical compositions comprising cannabidiol derivatives
07/20/2010CA2399001C Integrin expression inhibitor
07/20/2010CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it
07/17/2010WO2010067131A1 P38 map kinase inhibitors
07/15/2010WO2010080712A2 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
07/15/2010WO2010080455A1 New salts
07/15/2010WO2010079914A2 A composition comprising the compound isolated from the extract of rubiae radix for preventing and treating inflammatory diseases
07/15/2010WO2010079668A1 Olefin compound
07/15/2010WO2010079514A1 A process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate
07/15/2010WO2010078730A1 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection
07/15/2010WO2009033282A8 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects
07/15/2010US20100179227 Production method of hop preparation, hop preparation, anti-inflammatory agent, food product and beverage, and oral product
07/15/2010US20100179225 POI Prevention
07/15/2010US20100179203 Novel pyrazole derivatives useful as potassium channel modulators
07/15/2010US20100179201 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same
07/15/2010US20100179192 Use of nitric oxide releasing compounds in the treatment of chronic pain
07/15/2010US20100179189 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
07/15/2010US20100179185 Novel Aminothienopyridinone Derivatives Processes for Preparing Them and Pharmaceutical Compositions Thereof
07/15/2010US20100179177 Heterocyclic compounds and their uses
07/15/2010US20100179176 V3 antagonists for the treatment or prevention of chronic pain
07/15/2010US20100179167 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
07/15/2010US20100179165 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
07/15/2010US20100179164 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
07/15/2010US20100179143 Naphthyridine, derivatives as p13 kinase inhibitors
07/15/2010US20100179141 Novel jnk inhibitors
07/15/2010US20100179140 Indenoisoquinolinone analogs and methods of use thereof
07/15/2010US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments
07/15/2010US20100179138 Isozazole Compounds As Inhibitors Of Heat Shock Proteins
07/15/2010US20100179126 Thiolactams and uses thereof
07/15/2010US20100179123 Thienopyrimidines useful as aurora kinase inhibitors
07/15/2010US20100179103 Curcumin cyclodextrin combination for preventing or treating various diseases
07/15/2010US20100179100 Medicinal forms of phospholipid preparations and methods for their preparation
07/15/2010US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa
07/15/2010US20100179089 Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly
07/15/2010US20100178368 Plant extract and its therapeutic use
07/15/2010US20100178365 Epicatechin deficient green tea
07/15/2010US20100178354 Remedy
07/15/2010US20100178349 Pharmaceutical formulation for the production of rapidly disintegrating tablets
07/15/2010US20100178344 Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles
07/15/2010US20100178335 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability
07/15/2010US20100178296 Antibodies to cd200r
07/15/2010US20100178280 Use of sirt7 for treating age-related diseases
07/15/2010US20100178246 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma
07/15/2010US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
07/15/2010CA2748181A1 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
07/15/2010CA2747558A1 New salts
07/14/2010EP2206772A2 Method of collecting placental stem cells
07/14/2010EP2206720A1 Albumin fusion proteins
07/14/2010EP2206713A1 Beta-carbolines useful for treating inflammatory disease
07/14/2010EP2206702A1 Bicyclic compound, production and use thereof
07/14/2010EP2206511A1 Protein a compositions and methods of use
07/14/2010EP2206502A1 Polymer conjugate of steroid
07/14/2010EP2206499A1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
07/14/2010EP2205616A1 Novel sulfated oligosaccharide derivatives
07/14/2010EP2205599A1 Cgrp antagonists
07/14/2010EP2205594A1 1,3,5-trisubstituted triazole derivative
07/14/2010EP2205590A1 Cgrp antagonists
07/14/2010EP2205585A1 Quinoline derivatives used to treat inflammatory and allergic diseases
07/14/2010EP2205583A2 N-heterocyclic biaryl carboxamides as ccr receptor antagonists
07/14/2010EP2205569A1 Alkylthio pyrimidines as crth2 antagonists